N. Al Shaye, J. Eames / Tetrahedron Letters 51 (2010) 5892–5895
5895
O
O
O
References and notes
O
LiOH, H2O2
H2O, THF
Ph
Ph
Ph
OH
N
O
HN
Ph
O
1. (a) Sonawane, H. R.; Bellur, N. S.; Ahuja, J. R.; Kulkarni, D. G. Tetrahedron:
Asymmetry 1992, 3, 163; (b) Fuji, K.; Node, M.; Tanaka, F.; Hosoi, S. Tetrahedron
Lett. 1989, 30, 2825; (c) Larsen, R. D.; Corley, E. G.; Davis, P.; Reider, P. J.;
Grabowski, E. J. J. J. Am. Chem. Soc. 1989, 111, 7650; (d) Alper, H.; Hamel, N. J.
Am. Chem. Soc. 1990, 112, 2803; (e) Piccolo, O.; Spreafico, F.; Visentin, G.; Valoti,
E. J. Org. Chem. 1985, 50, 3945; (f) Piccolo, O.; Azzena, U.; Melloni, G.; Delogu,
G.; Valoti, E. J. Org. Chem. 1991, 56, 183; (g) Ohta, T.; Takaya, H.; Kitamura, M.;
Nagai, K.; Noyori, R. J. Org. Chem. 1987, 52, 3174.
2. (a) Coumbarides, G. S.; Eames, J.; Flinn, A.; Northen, J.; Yohannes, Y. Tetrahedron
Lett. 2005, 46, 849; (b) Coumbarides, G. S.; Dingjan, M.; Eames, J.; Flinn, A.;
Motevalli, M.; Northen, J.; Yohannes, Y. Synlett 2006, 101; (c) Boyd, E.; Chavda,
S.; Coulbeck, E.; Coumbarides, G. S.; Dingjan, M.; Eames, J.; Flinn, A.;
Krishnamurthy, A. K.; Namutebi, M.; Northen, J.; Yohannes, Y. Tetrahedron:
Asymmetry 2006, 17, 3406; (d) Coulbeck, E.; Coumbarides, G. S.; Dingjan, M.;
Eames, J.; Ghilagaber, S.; Yohannes, Y. Tetrahedron: Asymmetry 2006, 17, 3386;
(e) Boyd, E.; Chavda, S.; Eames, J.; Yohannes, Y. Tetrahedron: Asymmetry 2007,
18, 476; (f) Coulbeck, E.; Eames, J. Tetrahedron: Asymmetry 2007, 18, 2313; (g)
Coumbarides, G. S.; Dingjan, M.; Eames, J.; Flinn, A.; Northen, J. Chirality 2007,
19, 321; (h) Chavda, S.; Coulbeck, E.; Eames, J.; Motevalli, M. Tetrahedron:
Asymmetry 2008, 19, 1274.
Me
Me
Ph
Ph
Ph
(R,S)-20; 94%
(S)-36; 82%; 98% e.e.
(S,R,S)-syn-21
O
O
O
O
Ph
LiOH, H2O2
H2O, THF
OH
N
O
HN
O
Et
Et
Ph
Ph
R)-1; 85%
(S)-37; 89%; >98% e.e.
(
(S,R)-syn-5
Scheme 8. Formation of enantiomerically pure 2-phenyl-propanoic acid (S)-36 and
butanoic acid (S)-37.
one 32 to the active ester 2 is not stereospecific and probably pro-
ceeds via a deprotonation/deprotonation ketene mechanism.
In an attempt to probe the complementarity of this resolution, we
next investigated the resolution of 4-phenyl-oxazolidin-2-ones
(rac)-1 using an enantiomerically pure active ester, pentafluorophe-
nyl 2-phenylbutanoate (R)-4 (Scheme 7). Treatment of the oxazoli-
din-2-one (rac)-1 in THF at À78 °C, with n-BuLi, followed by the
addition of pentafluorophenyl 2-phenylbutanoate (R)-4 in THF,
and stirring the resulting solution for 5 min, gave the oxazolidin-2-
one (S,S)-syn-5 in 22% yield with 92% de (Scheme 7). The remaining
oxazolidin-2-one (R)-1 was recovered with 26% ee (Scheme 7).
Simple hydrolysis of these enantiomerically pure oxazolidin-2-
one adducts, such as (S,R,S)-syn-21 and (S,R)-syn-5, using a combina-
tion of LiOH and H2O2 in THF/H2O (3:1), gives access to the resolved
2-phenylpropanoic acid (S)-36 and 2-phenylbutanoic acid (S)-37 in
good yields with excellent enantiomeric excesses (Scheme 8).6
In conclusion, we have reported the kinetic resolution of a series
of pentafluorophenyl active esters, such as (rac)-2, using 4-aryl/
phenyl-substituted oxazolidin-2-ones, such as (R,S)-20, to give
the corresponding oxazolidin-2-one adduct (S,R,S)-syn-21 in good
yield (43%) with high levels of diastereocontrol (90% de). The levels
of diastereocontrol were found to be highly dependent on the
structural nature of the 4-substituted oxazolidin-2-one. Those
oxazolidin-2-ones that contained a 4-aryl/phenyl-substituted ring
gave higher levels of diastereoselectivity than those contained a
simple 4-alkyl substituent. Increasing the steric demand of these
oxazolidin-2-ones, by using 5,5-diphenyl substitution15 [in the
case of oxazolidin-2-ones (S)-28 and (S)-32] increased the likeli-
hood of non-stereospecific addition pathways. The recovered ac-
tive esters were isolated in good yield (9–90%) and were found
to be enantiomerically enriched with up to 80% ee.
3. (a) Coumbarides, G. S.; Dingjan, M.; Eames, J.; Flinn, A.; Northen, J.; Yohannes,
Y. Tetrahedron Lett. 2005, 46, 2897; (b) Yohannes, Y. Ph.D. Thesis, University of
London, 2004.
4. Al Shaye, N.; Broughton, T. W.; Coulbeck, E.; Eames, J. Synlett 2009, 960.
5. The level of diastereocontrol was found to be excellent [measured by 1H NMR
(400 MHz) spectroscopy]. For oxazolidin-2-one (S,S)-anti-3, the PhCHN double
doublet is at 5.32 ppm (1H, dd, J = 8.8 and 3.2). Whereas, for oxazolidin-2-one
(R,S)-syn-3, the PhCHN double doublet is 5.45 ppm (1H, dd, J = 9.0 and 5.1).
6. The enantiomeric excess was determined through hydrolysis of the active ester
to give the corresponding carboxylic acid. The enantiomeric excess of this
carboxylic acid was determined through statistical anhydride formation by
treatment with DCC. For further information, see: Coulbeck, E.; Eames, J.
Tetrahedron: Asymmetry 2009, 20, 635.
7. After 1 min—the active ester (S)-2 was recovered in 30% yield with 90% ee. The
enantiomeric excess was confirmed by specific rotation and self-coupling; see
Ref. 6.
8. For 1 equiv—the active ester (S)-2 was recovered in 35% yield with 44% ee. The
enantiomeric excess was confirmed by specific rotation and self-coupling; see
Ref. 6.
9. The following enantiomerically enriched active esters were isolated; Scheme 4,
entry 1—(S)-2; 35%; 46% ee; entry 2—(S)-4; 43%; 80% ee; entry 3—(rac)-6; 90%;
entry 4—(S)-8; 42%; 55% ee; entry 5—(S)-10; 42%; 74% ee; entry 6—(S)-12; 20%;
65% ee; entry 7—(S)-14; 37%; 63% ee.
10. The% ee of the recovered active esters were comparable (within experimental
error) to the theoretical value based on the %yield ( 10%) and %de of the
oxazolidin-2-one adduct.
11. Addition of the lithiated oxazolidin-2-one (S)-1 to the active ester (rac)-12 is
stereospecific as addition to the enantiomerically pure active ester (R)-12 gave
exclusively the major diastereoisomeric oxazolidin-2-one (R,S)-syn-13 in 54%
yield with >98% de.
12. The enantiomerically enriched active ester 2 was isolated; Scheme 5, entry
1—35%; (S)-54% ee; entry 2—14%; (S)-23% ee; entry 3—59%; (S)-17% ee; entry 4—
32%; (S)-53% ee; entry 5—24%; (R)-56% ee; entry 6—15%; (R)-54% ee; entry
7—37%; (R)-66% ee; entry 8—17%; (R)-64% ee.
13. The enantiomerically enriched active ester 2 was isolated; Scheme 6, entry
1—25%; (R)-32% ee; entry 2—17%; (R)-68% ee; entry 3—32%; (R)-37% ee; entry
4—15%; (R)-19% ee; entry 5—14%; (S)-44% ee; 4%; (S)-4% ee; entry 8—31%; (R)-
36% ee; entry 9—37%; (S)-36% ee; entry 10—9%; (S)-16% ee; entry 12—19%; (R)-
33% ee; entry 14—50%; 6% ee.
14. The stereochemistry of the Seebach adducts, (R,S)-syn-17, (S,S)-anti-29 and
(S,S)-anti-33, were confirmed by stereospecific synthesis.
Acknowledgements
15. (a) Bull, S. D.; Davies, S. G.; Garner, A. C.; Kruchinin, D.; Key, M. S.; Roberts, P.
M.; Savory, A. D.; Smith, A. D.; Thomson, J. E. Org. Biomol. Chem. 2006, 4, 2945;
(b) Gaul, C.; Schweizer, B. W.; Seiler, P.; Seebach, D. Helv. Chim. Acta 2002, 85,
1546; (c) Hintermann, T.; Seebach, D. Helv. Chim. Acta 1998, 81, 2093.
We are grateful to the Saudi Government for financial support
(to N.A.S), and the EPSRC National Mass Spectrometry Service
(Swansea) for accurate mass determinations.